Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases

Journal of Histochemistry and Cytochemistry

Volumn 55, Issue 2, 2007, Pages 111-118

  Iki, Katsumichi ^a   Pour, Parviz M ^a,b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Diabetes; Immunohistochemistry; Islet amyloid polypeptide; Islets; Morphometry

Indexed keywords

AMYLIN; GLUCAGON; INSULIN; PANCREAS POLYPEPTIDE; SOMATOSTATIN;

ADULT; AGED; ARTICLE; CELL POPULATION; CELL SECRETION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET DELTA CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLOID; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON; GLUCAGON-SECRETING CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PANCREATIC POLYPEPTIDE; PANCREATIC POLYPEPTIDE-SECRETING CELLS; REFERENCE VALUES; SOMATOSTATIN; SOMATOSTATIN-SECRETING CELLS;

EID: 33846411850     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.6A7024.2006     Document Type: Article

References (33)

1. Ahren B, Gutniak M (1997) No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes. Eur J Endocrinol 137:643-649
2. Bonner-Weir S (2001) β-cell turnover. Its assessment and implications. Diabetes 50(suppl 1):S20-24
3. Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC (2004) Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 53:1509-1516
4. Butler AE, Janson J, Soeller WC, Butler PC (2003) Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304-2314
5. Clark A, de Koning EJ, Hattersley AT, Hansen BC, Yajnik CS, Poulton J (1995) Pancreatic pathology in non-insulin dependent diabetes (NIDDM). Diabetes Res Clin Pract 28(suppl):S39-47
6. Corbett J, Serup P, Bonner-Weir S, Nielsen JH (1997) Beta-cell ontogeny: growth and death. Diabetologia 40(suppl 3):B27-32
7. De Vroede M, Foriers A, Van de Winkel M, Madsen O, Pipeleers D (1992) Presence of islet amyloid polypeptide in rat islet B and D cells determines parallelism and dissociation between rat pancreatic islet amyloid polypeptide and insulin content. Biochem Biophys Res Commun 182:886-893
8. Enoki S, Mitsukawa T, Takemura J, Nakazato M, Aburaya J, Toshimori H, Matsukara S (1992) Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 15:97-102
9. Gerich JE (1981) Somatostatin and diabetes. Am J Med 70:619-626
10. Hanabusa T, Kubo K, Oki C, Nakano Y, Okai K, Sanke T, Nanjo K (1992) Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 15:89-96
11. Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC (1996) Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:7283-7288
12. Johnson KH, O'Brien TD, Jordan K, Westermark P (1989) Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. Am J Pathol 135:245-250
13. Lindstrom T, Leckstrom A, Westermark P, Arnqvist HJ (1997) Effect of insulin treatment on circulating islet amyloid polypeptide in patients with NIDDM. Diabet Med 14:472-476
14. Ma Z, Westermark GT, Li ZC, Engstrom U, Westermark P (1997) Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in amyloidogenesis. Diabetologia 40:793-801
15. Ma Z, Westermark P, Westermark GT (2000) Amyloid in human islets of Langerhans: immunologic evidence that islet amyloid polypeptide is modified in amyloidogenesis. Pancreas 21:212-218
16. Madsen OD, Nielsen JH, Michelsen B, Westermark P, Betsholtz C, Nishi M, Steiner DF (1991) Islet amyloid polypeptide and insulin expression are controlled differently in primary and transformed islet cells. Mol Endocrinol 5:143-148
17. Marzban L, Park K, Verchere CB (2003) Islet amyloid polypeptide and type 2 diabetes. Exp Gerontol 38:347-351
18. Mulder H, Ahren B, Stridsberg M, Sundler F (1995a) Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rats islets following dexamethasone treatment. Diabetologia 38:395-402
19. Mulder H, Ahren B, Sundler F (1995b) Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents. Mol Cell Endocrinol 114:101-109
20. Mulder H, Ahren B, Sundler F (1996) Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats. Diabetologia 39:649-657
21. Mulder H, Gebre-Medhin S, Betsholtz C, Sundler F, Ahren B (2000a) Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes. Am J Physiol Endocrinol Metab 278:E684-691
22. Mulder H, Lindh AC, Ekblad E, Westermark P, Sundler F (1994) Islet amyloid polypeptide is expressed in endocrine cells of the gastric mucosa in the rat and mouse. Gastroenterology 107:712-719
23. Mulder H, Martensson H, Sundler F, Ahren B (2000b) Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/ 6J mice. Metabolism 49:1518-1522
24. Orci L, Baetens D, Rufener C, Amherdt M, Ravazzola M, Studer P, Malaisse-Lagae F, et al. (1976) Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci USA 73:1338-1342
25. Pour PM (2006) Centroacinar cells-a neglected essential element of the pancreas. In Pour PM, ed. Toxicology of the Pancreas. Boca Raton, FL, Taylor & Francis
26. Pour PM, Kazakoff K, Dulany K (1994) A new technique for simultaneous demonstration of 4 tumor-associated antigens in pancreatic cancer cells. Zentralbl Pathol 140:397-401
27. Rocken C, Linke RP, Saeger W (1992) Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series. Virchows Arch A Pathol Anat Histopathol 421:339-344
28. Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, Unger RH (1982) Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31:694-700
29. Stridsberg M, Sandler S, Wilander E (1993) Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of beta-cell function. Regul Pept 45:363-370
30. Stridsberg M, Wilander E (1991) Islet amyloid polypeptide (IAPP). A short review. Acta Oncol 30:451-456
31. Takada K, Kanatsuka A, Tokuyama Y, Yagui K, Nishimura M, Saito Y, Makino H (1996) Islet amyloid polypeptide/amylin contents in pancreas change with increasing age in genetically obese and diabetic mice. Diabetes Res Clin Pract 33:153-158
32. Tokuyama T, Yagui K, Yamaguchi T, Huang CI, Kuramoto N, Shimada F, Miyazaki J, et al. (1997) Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic beta cells. Metabolism 46:1044-1051
33. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, et al. (2003) Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300-2308